The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The impact of glycosylation on monoclonal antibody conformation and stability
Open accessAbstract
Antibody glycosylation is a common post-translational modification and has a critical role in antibody effector function. The use of glycoengineering to produce antibodies with specific glycoforms may be required to achieve the desired therapeutic efficacy. However, the modified molecule could have unusual behavior during development due to the alteration of its intrinsic properties and stability. In this study, we focused on the differences between glycosylated and deglycosylated antibodies, as aglycosyl antibodies are often chosen when effector function is not desired or unimportant. We selected three human IgG1 antibodies and used PNGase F to remove their oligosaccharide chains. Although there were no detected secondary or tertiary structural changes after deglycosylation, other intrinsic properties of the antibody were altered with the removal of oligosaccharide chains in the Fc region. The apparent molecular hydrodynamic radius increased after deglycosylation based on size-exclusion chromatography analysis. Deglycosylated antibodies exhibited less thermal stability for the CH2 domain and less resistance to GdnHCl induced unfolding. Susceptibility to proteolytic cleavage demonstrated that the deglycosylated version was more susceptible to papain. An accelerated stability study revealed that deglycosylated antibodies had higher aggregation rates. These changes may impact the development of aglycosyl antibody biotherapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Niesen, F. H., Berglund, H., & Vedadi, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.321 · Cited by 2,408
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307
Effects of glycosylation on the stability of protein pharmaceuticals
Solá, R. J., & Griebenow, K. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21504 · Cited by 646
Design of therapeutic proteins with enhanced stability
Chennamsetty, N., Voynov, V., Kayser, V., Helk, B., & Trout, B. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904191106 · Cited by 598
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
Jefferis, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.04.007 · Cited by 330
Mimura, Y., Church, S., Ghirlando, R., Ashton, P. R., Dong, S., Goodall, M., Lund, J., & Jefferis, R. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00105-x · Cited by 329
Contribution of Variable Domains to the Stability of Humanized IgG1 Monoclonal Antibodies
Ionescu, R. M., Vlasak, J., Price, C., & Kirchmeier, M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21104 · Cited by 313
Kanai, S., Liu, J., Patapoff, T. W., & Shire, S. J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21322 · Cited by 304
Yamaguchi, Y., Nishimura, M., Nagano, M., Yagi, H., Sasakawa, H., Uchida, K., Shitara, K., & Kato, K. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.10.002 · Cited by 204
High throughput thermostability screening of monoclonal antibody formulations
He, F., Hogan, S., Latypov, R. F., Narhi, L. O., & Razinkov, V. I. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21955 · Cited by 192
Non-enzymatic hinge region fragmentation of antibodies in solution
Cordoba, A. J., Shyong, B.-J., Breen, D., & Harris, R. J. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.12.033 · Cited by 188
Zhou, Q., Shankara, S., Roy, A., Qiu, H., Estes, S., McVie‐Wylie, A., Culm‐Merdek, K., Park, A., Pan, C., & Edmunds, T. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21598 · Cited by 184
Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies
Kayser, V., Chennamsetty, N., Voynov, V., Forrer, K., Helk, B., & Trout, B. L. (2011) · Biotechnology Journal · doi:10.1002/biot.201000091 · Cited by 172
Aggregation-Prone Motifs in Human Immunoglobulin G
Chennamsetty, N., Helk, B., Voynov, V., Kayser, V., & Trout, B. L. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.028 · Cited by 156
Ghirlando, R., Lund, J., Goodall, M. D., & Jefferis, R. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00029-2 · Cited by 115
Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain
Raju, T. S., & Scallon, B. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.030 · Cited by 112
Fragmentation of a Recombinant Monoclonal Antibody at Various pH
Gaza‐Bulseco, G., & Liu, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9606-3 · Cited by 95
Brandt, J. P., Patapoff, T. W., & Aragón, S. R. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.05.003 · Cited by 92
Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody
Liu, H., Gaza‐Bulseco, G., Tao, X., & Chumsae, C. M. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.07.012 · Cited by 91
Fc Glycans Terminated with N-Acetylglucosamine Residues Increase Antibody Resistance to Papain
Raju, T. S., & Scallon, B. J. (2007) · Biotechnology Progress · doi:10.1021/bp070118k · Cited by 76
Folding Mechanism of the CH2 Antibody Domain
Feige, M. J., Walter, S., & Büchner, J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.033 · Cited by 73
Detection of IgG Aggregation by a High Throughput Method Based on Extrinsic Fluorescence
He, F., Phan, D. H. T., Hogan, S., Bailey, R. W., Becker, G. W., Narhi, L. O., & Razinkov, V. I. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22036 · Cited by 64
Kwon, K., & Yu, M. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(96)00143-2 · Cited by 62
In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase
Warnock, D. E., Bai, X., Autote, K., Gonzales, J., Kinealy, K., Yan, B., Qian, J., Stevenson, T., Zopf, D. A., & Bayer, R. J. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20658 · Cited by 56
Self-citationSerrato, J. A., Hernandez, V. A., Estrada‐Mondaca, S., Palomares, L. A., & Ramírez, O. T. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20060216 · Cited by 52
Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation
Voynov, V., Chennamsetty, N., Kayser, V., Helk, B., Forrer, K., Zhang, H., Fritsch, C., Heine, H., & Trout, B. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008425 · Cited by 49
The Production of Glycoproteins by Transient Expression in Mammalian Cells
Nettleship, J. E., Rahman-Huq, N., & Owens, R. J. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-196-3_16 · Cited by 47
pH dependent effect of glycosylation on protein stability
Wang, W., Antonsen, K. P., Wang, Y. J., & Wang, D. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.10.008 · Cited by 31
Cabrera, G., Cremata, J. A., Valdés, R., García, R., González, Y., Montesino, R., Gómez, H., & González, M. (2004) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20040032 · Cited by 28
Gaza‐Bulseco, G., Hickman, K., Sinicropi-Yao, S. L., Hurkmans, K., Chumsae, C. M., & Liu, H. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.01.014 · Cited by 16
Cited by
Nanoparticle-Based Immunochemical Biosensors and Assays: Recent Advances and Challenges
Farka, Z., Juřík, T., Kovář, D., Trnková, L., & Skládal, P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00037 · Cited by 694
Characterization of Therapeutic Antibodies and Related Products
Beck, A., Wagner-Rousset, E., Ayoub, D., Van Dorsselaer, A., & Sanglier-Cianférani, S. (2013) · Analytical Chemistry · doi:10.1021/ac3032355 · Cited by 587
Glycosylation: mechanisms, biological functions and clinical implications
He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 499
Site-selective modification strategies in antibody–drug conjugates
Walsh, S. J., Bargh, J. D., Dannheim, F. M., Hanby, A. R., Seki, H., Counsell, A. J., Ou, X., Fowler, E., Ashman, N., Takada, Y., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00310g · Cited by 461
Higel, F., Seidl, A., Sörgel, F., & Friess, W. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.01.005 · Cited by 360
Metadata
- Authors
- Zheng, K., Bantog, C., & Bayer, R.
- Venue
- mAbs
- Publisher
- Informa UK Limited
- Published
- 2011-11
- Volume
- 3
- Issue
- 6
- Pages
- 568-576
- ISSN
- 1942-0862 (ISSN-L)
- 1942-0870
- OpenAlex
- W2034515273
- Cited by
- 342
- References
- 32
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.